PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmalaria
MeSH D008288 - malaria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D011528:Protozoan infections
$
Success rate
D000096724:Mosquito-borne diseases
0 Companies
0 Drugs
Success rate
D008288: 
Malaria
D008289:Avian malaria
$
Success rate
D016778:Falciparum malaria
D016779:Cerebral malaria
$
Success rate
D016780:Vivax malaria
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaChloroquine Chloroquine  1982-01-13   
Hydroxychloroquine Hydroxychloroquine  1994-09-30   
Pyrimethamine Pyrimethamine  2021-08-13   
Quinine Quinine  2012-09-28   
Novast LaboratoriesPrimaquine Primaquine  2016-06-23   
Quinine Quinine  2015-07-22   
Glenmark PharmaceuticalsAtovaquone Atovaquone  2018-11-21   
Atovaquone, Proguanil Atovaquone Proguanil  2011-01-12   
MylanAtovaquone, Proguanil Atovaquone Proguanil  2014-05-27   
GSKTafenoquine Krintafel  2018-07-20   
Atovaquone, Proguanil Malarone  2000-07-14   
Atovaquone Mepron  1992-11-25   
RochePyrimethamine, Sulfadoxine Fansidar  1982-01-01   
Mefloquine Lariam  1989-05-02   
Lupin ResearchAtovaquone Atovaquone  2018-09-11   
Quinine Quinine  2015-04-24   
SandozHydroxychloroquine Hydroxychloroquine  1995-11-30   
Mefloquine Mefloquine  2002-02-20   
NovartisLumefantrine, Artemether Coartem  2009-04-07   
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
68%
40/59
Phase 2
71%
30/42
Phase 3
60%
36/60
Approved: 15Overall Success rate: 29%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
GSK
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use